Line 32: |
Line 32: |
| | | |
| ==Antigenicity== | | ==Antigenicity== |
− | *Main envelope protein: gp70
| + | Viral subgroups have been categorised based on the different abnormalities detected in the host cellular envelope protein gp70. This protein interacts with a cellular receptor, and can prevent already infected cells from being targeted by further viral organisms. |
− | *3 antigenic subgroups:
| |
− | *Group A
| |
− | **is transmitted between cats
| |
− | **is monotypic: one vaccine covers all isolates
| |
− | **causes '''lymphosarcoma'''
| |
− | *Group B:
| |
− | **is recombinant with transmissible FeLV-A
| |
− | **increases the chance of '''thymic tumors'''
| |
− | *Group C:
| |
− | **is a mutant of A
| |
− | **isolates are rare, and occur as A+C mixtures
| |
− | **increases chances of '''anemia'''
| |
| | | |
| + | There are 3 antigenic subgroups which are defined by the gp70 regulated viral response: |
| + | *Group A is transmitted between cats and is monotypic: one vaccine covers all isolates. Infection with this viral subgroup leads to '''lymphosarcoma'''. |
| + | *Group B is recombinant with transmissible FeLV-A; infection with viruses of this subgroup increases the chance of developing '''thymic tumors'''. |
| + | *Group C is a mutant of subgroup A. Isolates are rare, and occur as A+C mixtures, leading to an increased chance of developing '''anemia'''. |
| | | |
| ==Diagnosis== | | ==Diagnosis== |